.jpg)
1 hour ago
4
Article content
Article content
Tracking Myelin and Alzheimer’s Blood Biomarkers to Explain Brain Lesions
Article content
Matthias Hebisch, PhD,
Article content
Massachusetts General Hospital (Mass General)
Article content
Article content
Modeling Dementia in Brain Organoids with Alzheimer’s Disease
Article content
Martin Hsu, PhD,
Article content
University of North Carolina at Chapel Hill
Article content
Article content
Uncovering a Protein in Astrocytes that Drives Alzheimer’s Disease
Article content
Heidi Jacobs, PhD,
Article content
Massachusetts General Hospital (Mass General)
Article content
Article content
Dorsal Raphe Nucleus: Seam for Earliest Detection of Tau and Symptoms
Article content
Selene Lomoio, PhD,
Article content
Icahn School of Medicine at Mount Sinai
Article content
Article content
A Human Platform to Decode Brain Changes in Alzheimer’s Disease
Article content
Article content
Co-Principal Investigator: Valentina Fossati, PhD
Article content
Amanda McQuade, PhD,
Article content
University of California, San Francisco
Article content
Article content
Understanding How Genetic Risk for Alzheimer’s Disease Impacts Immune Function
Article content
Sarah Ocañas, PhD,
Article content
Oklahoma Medical Research Foundation
Article content
Article content
The Ovary-Brain Inflammatory Axis in Alzheimer’s Disease
Article content
Article content
Co-Principal Investigator: Jeffrey Mason, PhD
Article content
Daniel Panyard, PhD,
Article content
Stanford University
Article content
Article content
Identifying How Cardiovascular Disease Affects Risk of Alzheimer’s Disease
Article content
Justin Perry, PhD,
Article content
Memorial Sloan Kettering Cancer Center
Article content
Article content
Does Fructose Drive Neurodegenerative Disease?
Article content
Dominika Pilat, PhD,
Article content
Massachusetts General Hospital (Mass General)
Article content
Article content
A Nasal Route to Deliver RNA-Based Treatment for Alzheimer’s Disease
Article content
Saima Rathore, PhD,
Article content
Emory University
Article content
Article content
AI-Informed Signature of Alzheimer’s Disease and Related Dementias to Model Longitudinal Disease Trajectories
Article content
Article content
Co-Principal Investigators: Allan I. Levey, MD, PhD and Nicholas Seyfried, PhD
Article content
Austin Reynolds, PhD
Article content
, University of North Texas Health Science Center at Fort Worth
Article content
Article content
Genetic Ancestry Impacts Mitochondrial Dysfunction in Alzheimer’s Disease
Article content
Article content
Co-Principal Investigators: Nicole Phillips, PhD, and Robert Clinton Barber, PhD
Article content
Leonardo Rivera- Rivera, PhD,
Article content
University of Wisconsin-Madison
Article content
Article content
Evaluating Cerebral Small Vessel Disease in Alzheimer’s with MRI
Article content
Vladislava Segen, PhD
Article content
, German Center for Neurodegenerative Diseases (Germany)
Article content
Article content
Using Navigation to Detect Early Changes in Alzheimer’s Disease
Article content
Gowoon Son, PhD,
Article content
Mayo Clinic Jacksonville
Article content
Article content
Why Alzheimer’s Disease Targets Some Cells First: A Driver in the Anterior Hypothalamus
Article content
Vivek Swarup, PhD
Article content
, University of California, Irvine
Article content
Article content
Beyond Pathology: Mapping How Some Brains Stay Sharp in Extreme Old Age
Article content
Christina Theodoris, MD, PhD
Article content
Article content
, Gladstone Institutes
Article content
Article content
Mapping How Brain Cells Change Over Aging to Predict Therapeutic Targets
Article content
Tomas Vikner, PhD
Article content
, University of Wisconsin-Madison
Article content
Article content
Cerebrospinal Fluid Flow Dynamics in Alzheimer’s Disease
Article content
Jennifer Sachiko Yokoyama, PhD
Article content
, University of California, San Francisco
Article content
Article content
Autoimmune Contributions to Alzheimer’s Disease
Article content
Article content
Co-Principal Investigator: Joseph J. Sabatino, MD, PhD
Article content
Keir Yong, PhD
Article content
, University College London (U.K.)
Article content
Article content
Visual System Vulnerability in Dementia: From Detection to Determinants
Article content
Article content
Co-Principal Investigators: André Altmann, PhD and David M. Cash, PhD
Article content
QI Zhang, PhD
Article content
,
Article content
Article content
Emory University
Article content
Article content
Uncovering New Early Detection Markers for Alzheimer’s Disease
Article content
Haoyue Zhou, PhD
Article content
, Gladstone Institutes
Article content
Article content
How Blood Proteins Influence Brain Health and Alzheimer’s Disease
Article content
Macular Degeneration Research
Article content
Twenty million U.S. adults have
Article content
Article content
—the leading cause of vision loss in Americans aged 65 and older. Early detection and treatment are crucial to slowing the disease progression and preventing permanent vision loss. Macular Degeneration Research grant recipients are exploring a wide range of innovative scientific approaches to prevent, treat, and cure macular degeneration—from developing novel methods to model AMD to investigating potential new treatments for both dry and wet AMD.
Article content
2026 Macular Degeneration Research grant recipients:
Article content
Ryoji Amamoto, PhD
Article content
, Massachusetts Eye and Ear Infirmary (Harvard)
Article content
Article content
Promoting Cone Survival in Dry AMD
Article content
Marco Bassetto, PharmD, PhD
Article content
,
Article content
University of California, Irvine
Article content
Article content
Development of a New Drug Delivery System to Treat Retinal Inflammation
Article content
Celia Bisbach, PhD
Article content
, University of Wisconsin-Madison
Article content
Article content
Targeting and Removing Harmful Proteins to Treat Wet AMD
Article content
Suman Chaudhary, PhD
Article content
, Schepens Eye Research Institute of Mass. Eye and Ear
Article content
Article content
A Novel Antioxidant Therapy for Age-Related Macular Degeneration
Article content
Mark Draelos, MD, PhD
Article content
, University of Michigan
Article content
Article content
Studying Eye Blood Flow During Exercise Stress Tests
Article content
Anaïs Françon , PhD
Article content
, Hôpital Maisonneuve-Rosemont (Canada)
Article content
Article content
Role of Lack of Sleep in Blood Vessel Formation in Retinal Degeneration
Article content
Petra Larsen, MD, PhD
Article content
, German Center for Neurodegenerative Diseases (Germany)
Article content
Article content
Mapping the Molecular-Imaging Interface in AMD: A Multimodal Approach
Article content
Eric (Xiang) Ma, PhD
Article content
, Oklahoma Medical Research Foundation
Article content
Article content
Protecting Choroidal Blood Vessels to Prevent Vision Loss in AMD
Article content
Article content
Jason Miller, MD, PhD
Article content
, University of Michigan
Article content
Article content
RPE Lipid Degradation and Secretion in Age-Related Macular Degeneration
Article content
Sarah Palko, PhD
Article content
, Trinity College Dublin (Ireland)
Article content
Article content
Understanding How Müller Glia Contribute to Immune Cell Accumulation in AMD
Article content
Estelle (Sunghee) Park, PhD
Article content
, Purdue University
Article content
Article content
Uncovering the Hidden Link Between Liver Health and Macular Degeneration
Article content
Amir Vahabikashi, PhD
Article content
, Northeastern University
Article content
Article content
Human Retina-on-a-Chip: A Next-Generation Model for Age-Related Macular Degeneration
Article content
David Veysset, PhD
Article content
, Massachusetts General Hospital (Harvard)
Article content
Article content
Advancing AMD Diagnosis with Novel Spectroscopic Tools
Article content
Lily (Wenjing) Wu, PhD
Article content
, University of Oklahoma Health Sciences Center
Article content
Article content
Targeting Age-Related Vision Loss with the Power of Essential Fats
Article content
National Glaucoma Research
Article content
Around 4 million U.S. adults have
Article content
Article content
—a leading cause of blindness in the U.S. caused by damage to the optic nerve. Because there are often no early symptoms, as many as half of those affected may not even know they have it until irreversible vision loss has occurred. Early detection and treatments can help slow the disease’s progression.
Article content
National Glaucoma Research grant recipients are investigating a wide range of scientific approaches, including leveraging artificial intelligence to promote earlier detection and better identify who’s most at risk, developing novel treatments, and exploring ways to protect and regenerate the optic nerve that could restore vision.
Article content
2026 National Glaucoma Research grant recipients:
Article content
Navid Amini, PhD
Article content
, California State University, Los Angeles
Article content
Article content
How Glaucoma Patients Lift Their Feet and Use Smart Insoles to Walk Safely
Article content
Revathi Balasubramanian, PhD
Article content
, Columbia University
Article content
Article content
How Schlemm’s Canal Develops and What Goes Awry in Pediatric Glaucoma
Article content
Evan Cameron, PhD
Article content
, Cleveland Clinic – Lerner Research Institute
Article content
Article content
Understanding Astrocyte-Immune Cell Signaling in Glaucoma
Article content
Mark Christopher, PhD
Article content
, University of California, San Diego
Article content
Article content
Agentic Multimodal AI System for Glaucoma Management
Article content
Qi Cui, MD, PhD
Article content
, University of Pennsylvania, Perelman School of Medicine
Article content
Article content
Myeloid Cellular Responses in Hypertensive Glaucoma
Article content
Luca Della Santina, PhD, PharmD
Article content
, University of Houston
Article content
Article content
Using AI to Detect Loss of Connections Between Cells in the Eye
Article content
Stuart Gardiner, PhD
Article content
, Good Samaritan Foundation (Legacy Health System)
Article content
Article content
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
English (US)